⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

October 1, 2018Annals of Research HospitalsOpen Access

Building a better mousetrap in the immunologic treatment of acute myeloid leukemia

John L. Reagan Loren D. Fast

View Full Paper

Ask AI

Bookmark

Share

Abstract

Sallman et al . report on the successful use of chimeric antigen receptor modified T cells (CAR-T cells) utilizing a Natural Killer Group 2D (NKG2D) target in a patient with acute myeloid leukemia (1).

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Reagan et al. (2018) studied this question.

synapsesocial.com/papers/6a82aeee166743491475ac4a https://doi.org/10.21037/arh.2018.09.02

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 related papers. Consider them for comparative context:

1A translational approach to the renin-angiotensin-aldosterone system in heart failureAnnals of Research Hospitals · Sat,
2Novel insight on the impact of choline-deficiency in sepsisAnnals of Research Hospitals · Sat,
3The vitamin D paradox: high prevalence of deficiency in sunny Athens (Greece)Annals of Research Hospitals · Sat,
4Endothelial dysfunction in HIV infection: experimental and clinical evidence on the role of oxidative stressAnnals of Research Hospitals · Fri,
5Lipid peroxidation products and their role in neurodegenerative diseasesAnnals of Research Hospitals · Tue,

More from Annals of Research Hospitals

Respiratory infections: a global burdenSat,
Novel diagnostics of respiratory infection in the intensive care unitWed,
Sepsis and community-acquired pneumoniaFri,
Treatment guidelines for community-acquired pneumoniaFri,
Early, short and long-term mortality in community-acquired pneumoniaTue,